Skip to main content

Animations

MJFF Publications

4861 - 4870 of 6420 Results
Title
Year
  • Year
  • 2021
  • 2020
  • 2020
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Cognition-Related Functional Topographies in Parkinson’s Disease: Localized Loss of the Ventral Default Mode Network
    Journal Name: Cerebral Cortex
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/cercor/bhab148
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Observation of an α-synuclein liquid droplet state and its maturation into Lewy body-like assemblies
    Journal Name: Journal of Molecular Cell Biology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/jmcb/mjaa075
    Citation Count: 89
  • Summary Details
    OPEN
    Title: Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlaa153
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awab404
    Citation Count: 82
  • Summary Details
    OPEN
    Title: Orofacial pain in 1916 patients with early or moderate Parkinson disease
    Journal Name: PAIN Reports
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1097/pr9.0000000000000923
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease
    Journal Name: Pharmacogenetics and Genomics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/fpc.0000000000000445
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000012452
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Exploring the contribution of the mitochondrial disulfide relay system to Parkinson’s disease: the PINK1/CHCHD4 interplay
    Journal Name: Neural Regeneration Research
    Publisher: Medknow
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.4103/1673-5374.310679
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Will the COVID-19 Pandemic Finally Fuel Drug Repurposing Efforts?
    Journal Name: American Journal of Medical Quality
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/01.jmq.0000735440.58551.5b
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Incorporating Patient Preferences via Bayesian Decision Analysis
    Journal Name: Clinical Journal of the American Society of Nephrology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2215/cjn.12110720
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.